Lipidstoffwechsel aktuell: statininduzierte Myopathien.
LL Teichmann, M Fleck - Zeitschrift für Rheumatologie, 2010 - search.ebscohost.com
English Cardiovascular diseases are the most common causes of death in Germany and the
prevalence is increased in patients with inflammatory rheumatic diseases. Statins are often …
prevalence is increased in patients with inflammatory rheumatic diseases. Statins are often …
Statins and muscular side-effects
Statins are effective in the treatment of hypercholesterolemia for primary and secondary
prevention of cardiovascular disease. While most side effects of statins are mild and …
prevention of cardiovascular disease. While most side effects of statins are mild and …
Muscle problems due to statins: underestimated
SP Janssen, YM Smulders, VE Gerdes… - Nederlands Tijdschrift …, 2010 - europepmc.org
Statin-associated muscle problems are more common than the 1-5% prevalence reported in
large clinical trials. Observational studies show a prevalence of about 10%. Muscle …
large clinical trials. Observational studies show a prevalence of about 10%. Muscle …
Statin-Induced Myopathy and its Management.
C Buettner, MA Kriegel, RE Wells… - Current Medical …, 2010 - search.ebscohost.com
The article discusses a study on statin-induced myopathy and its management. There are
several factors that increase the risk of statin-induced myopathy, and an underlying …
several factors that increase the risk of statin-induced myopathy, and an underlying …
Statin-induced Myopathy: atherosclerotic cardiovascular disease
AJ Dalby - SA Heart, 2015 - journals.co.za
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide.
HMGCoA reductase inhibitors or" statins" reduce low density lipoprotein cholesterol and …
HMGCoA reductase inhibitors or" statins" reduce low density lipoprotein cholesterol and …
Muscle-and skeletal-related side-effects of statins: tip of the iceberg?
J Auer, H Sinzinger, B Franklin… - European Journal of …, 2016 - academic.oup.com
The clinical spectrum of muscle-and skeletal-related side-effects of statins includes varied
myalgias and weakness, an asymptomatic increase in the concentration of creatine kinase …
myalgias and weakness, an asymptomatic increase in the concentration of creatine kinase …
Statin-related muscle complaints: an underestimated risk
A Corsini - Cardiovascular drugs and therapy, 2005 - search.proquest.com
Controlled clinical studies and clinical experience over many years have proven that
virtually all patients at high cardiovascular risk benefit from lipid-lowering therapy with …
virtually all patients at high cardiovascular risk benefit from lipid-lowering therapy with …
Statin myopathy: A problem looking for a solution
KR Feingold - Atherosclerosis, 2015 - atherosclerosis-journal.com
Statins are one of the most commonly used classes of drugs because they have been shown
to significantly reduce cardiovascular disease in both primary and secondary prevention …
to significantly reduce cardiovascular disease in both primary and secondary prevention …
Safe use of statins: focus on muscle toxicity
V Kolovou, H Bilianou, G Kolovou - Clinical Lipidology, 2016 - Taylor & Francis
Muscle toxicity can be classified as myopathy, myalgia, myositis or rhabdomyolysis (RM).
RM can occur in patients with muscular dystrophy, alcoholic myopathy, peripheral artery …
RM can occur in patients with muscular dystrophy, alcoholic myopathy, peripheral artery …
Statin-induced myopathies
M Tomaszewski, KM Stępień, J Tomaszewska… - Pharmacological …, 2011 - Springer
Statins are considered to be safe, well tolerated and the most efficient drugs for the treatment
of hypercholesterolemia, one of the main risk factor for atherosclerosis, and therefore they …
of hypercholesterolemia, one of the main risk factor for atherosclerosis, and therefore they …